What: A recent survey revealed that 25% of women under 50 view health influencers as equally trustworthy as traditional providers, sparking debate about online health advice.
Key line: [Details not provided].
Source: PR Newswire.
What: A recent survey revealed that 25% of women under 50 view health influencers as equally trustworthy as traditional providers, sparking debate about online health advice.
Key line: [Details not provided].
Source: PR Newswire.
Increased daily steps reduce cardiovascular risk for postmenopausal women.
Trump’s FDA nominee suggests he’ll re-evaluate abortion pill safety.
A case at the Supreme Court could hit the entire Medicaid program by making key parts of the law unenforceable.
Carolina Public Press highlights potential solutions to the maternal care crisis in rural areas of North Carolina.
Study links higher menopausal symptom burden to dementia markers.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
Mother Jones covers the arrest of a midwife in Texas and the ongoing dangers of the state’s abortion bans.
WalletHub ranks the best and worst states for women, factoring in health metrics.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
A University of Oklahoma study found that waiting more than 42 days for certain breast cancer surgeries increased mortality risk.
XX Factor highlights concerns about cuts to NIH, CDC, and FDA that could impact women’s health research.
World Economic Forum explores why improving diagnostics in women’s health is key.
CVS earns ‘menopause-friendly’ accreditation by Midovia after training clinicians and increasing internal education.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
McKinsey examines how AI is poised to revolutionize the beauty industry, from marketing to product development.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
Oprah opens up about her menopause journey and brings national attention to a long-ignored health topic.
Marty Makary faces controversies as the new FDA commissioner.
New York Times honors the woman who funded and enabled the development of the birth control pill.
Study explores gene activation in women’s brains that may slow cognitive decline.